ZORBAX StableBond 300 C8, 2.1 x 100 mm, 3.5 µm. A reversed-phase C8 HPLC column with fully porous ZORBAX particles. StableBond technology ensures stability at low pH.
Specifications:
Brand: ZORBAX 300SB-C8
Hardware: SS
Inner Diameter (ID): 2.1 mm
LC Platform: Stainless Steel
Length: 100 mm
Maximum Temperature: 80 °C
Part Number Application Domain: Biopharma
Part Number Application: Monoclonal Antibodies (mABs)PeptidesProteins
Particle Size: 3.5 µm
Particle Type: Fully Porous
Phase: 300SB-C8
Pore Size: 300 Å
Pressure Rating: 400 bar
Separation Mode: Reversed Phase
Shipping Solvent: Acetonitrile/Water
Technique: LCLC & LC/MS
UNSPSC Code: 41115709
pH Range: 1-8
**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The ZORBAX StableBond 300 C8 column features a 2.1 x 100 mm dimension and 3.5 micron particle size, optimized for high-resolution reversed-phase liquid chromatography. Engineered with a robust end-capped C8 bonded phase on a 300 Angstrom pore silica, this column is particularly suited for the analysis and purification of peptides, small proteins, and other biomolecules that benefit from increased pore size. Its enhanced stability at low pH enables reproducible separations, making it an excellent choice for applications in proteomics, pharmaceutical development, and life science research. The StableBond chemistry ensures longevity, delivering consistent peak shapes and minimal column bleed. Designed for compatibility with Agilent 1100, 1200, 1260, and 1290 series LC systems as well as other HPLC and UHPLC platforms, this column integrates seamlessly into existing workflows. It is ideal for laboratories requiring reliable performance in high-throughput analytical and preparative methods. For comprehensive peptide mapping, protein characterization, or impurity profiling, it is also complemented by the ZORBAX family of reversed-phase columns in various pore sizes and phases. This product delivers precision and reproducibility, supporting advanced research and quality control in biopharmaceutical and biotechnology environments.